Methodological aspects of the oxygenscan in sickle cell disease: A need for standardization
Minke A.E. Rab(Utrecht University), Philippe Connes(Université Claude Bernard Lyon 1), Vivien Sheehan(Emory University), Romain Fort(Hospices Civils de Lyon), Élie Nader(Université Claude Bernard Lyon 1), Céline Renoux(Lyon 1 Université), Philippe Joly(Lyon 1 Université), Richard van Wijk(Utrecht University), Brigitte A. van Oirschot(Utrecht University), Celeste K. Kanne(Emory Healthcare), Eduard J. van Beers(Utrecht University), Jennifer Bos(Utrecht University), Camille Boisson(Lyon 1 Université)
Cited by 25
Related Papers
The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis
|Blood|2005|366
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162
AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes
|Haematologica|2020|81
Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients
|American Journal of Hematology|2019|76